Antimicrobial stewardship in patients with confirmed coronavirus disease 2019 (COVID-19).

Moore, Sarah E; Wilde, Ashley M; Bohn, Brian C; Song, Matthew; Schulz, Paul

Moore, Sarah E; Wilde, Ashley M; Bohn, Brian C; Song, Matthew; Schulz, Paul.

Moore SE; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky.
Wilde AM; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky.
Bohn BC; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky.
Song M; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky.
Schulz P; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, Kentucky.

Infect Control Hosp Epidemiol ; 43(11): 1698-1700, 2022 11.

Article in English | MEDLINE | ID: covidwho-1751599

ABSTRACT

ABSTRACT

Hospitalized coronavirus disease 2019 (COVID-19) patients receiving antibiotics (n = 173) were retrospectively assigned to the early or late discontinuation groups. The length of therapy was shorter in the early discontinuation group (3 vs 7 days; P < .0001). Mortality rates (14.3% vs 20.7%; P = .316) and length of stay (7 vs 9 days; P = .063) were similar.

Subject(s)

Antimicrobial Stewardship; COVID-19 Drug Treatment; Humans; Retrospective Studies; Hospitalization; Anti-Bacterial Agents/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antimicrobial Stewardship / COVID-19 Drug Treatment Type of study: Experimental Studies / Observational study / Randomized controlled trials Limits: Humans Language: English Journal: Infect Control Hosp Epidemiol Journal subject: Communicable Diseases / Nursing / Epidemiology / Hospitals Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google